论文部分内容阅读
1 文献类型治疗2 证据水平1b3 文献来源①Shepherd FA, Pereira J, Ciuleanu TE, et al.A randomized placebo-controlled trial or erlotinib in patients with advanced non-small cell lung cancer (NSCLC) following failure of 1st line or 2nd line chemotherapy. A National Cancer Ins